Barclays’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$207K Sell
6,706
-15,737
-70% -$387K ﹤0.01% 3669
2025
Q4
$468K Buy
22,443
+4,467
+25% +$83K ﹤0.01% 3889
2025
Q3
$282K Sell
17,976
-3,915
-18% -$80.8K ﹤0.01% 4142
2025
Q2
$435K Buy
21,891
+8,181
+60% +$166K ﹤0.01% 3833
2025
Q1
$243K Sell
13,710
-2,264
-14% -$73.8K ﹤0.01% 3933
2024
Q4
$738K Buy
15,974
+14,533
+1,009% +$615K ﹤0.01% 3582
2024
Q3
$43.7K Hold
1,441
﹤0.01% 4780
2024
Q2
$23.7K Sell
1,441
-1
-0.1% -$16 ﹤0.01% 4411
2024
Q1
$22.2K Hold
1,442
﹤0.01% 4743
2023
Q4
$23.5K Hold
1,442
﹤0.01% 4886
2023
Q3
$26.7K Sell
1,442
-406
-22% -$7.18K ﹤0.01% 4097
2023
Q2
$21.1K Buy
1,848
+20
+1% +$226 ﹤0.01% 4126
2023
Q1
$21.9K Hold
1,828
﹤0.01% 4641
2022
Q4
$15.6K Hold
1,828
﹤0.01% 4855
2022
Q3
$14K Hold
1,828
﹤0.01% 4192
2022
Q2
$20K Sell
1,828
-3,278
-64% -$38.6K ﹤0.01% 4414
2022
Q1
$81K Sell
5,106
-3,320
-39% -$68.6K ﹤0.01% 3887
2021
Q4
$389K Buy
8,426
+3,697
+78% +$212K ﹤0.01% 3306
2021
Q3
$316K Buy
4,729
+1,571
+50% +$129K ﹤0.01% 3401
2021
Q2
$337K Sell
3,158
-2,391
-43% -$283K ﹤0.01% 3294
2021
Q1
$845K Buy
5,549
+2,089
+60% +$340K ﹤0.01% 2876
2020
Q4
$579K Buy
3,460
+1,984
+134% +$353K ﹤0.01% 3152
2020
Q3
$230K Sell
1,476
-257
-15% -$51.8K ﹤0.01% 3754
2020
Q2
$362K Buy
1,733
+699
+68% +$144K ﹤0.01% 3602
2020
Q1
$193K Sell
1,034
-855
-45% -$201K ﹤0.01% 4330
2019
Q4
$456K Buy
1,889
+881
+87% +$170K ﹤0.01% 4381
2019
Q3
$171K Sell
1,008
-142
-12% -$32.1K ﹤0.01% 5088
2019
Q2
$224K Buy
1,150
+499
+77% +$108K ﹤0.01% 5008
2019
Q1
$172K Buy
651
+400
+159% +$73.1K ﹤0.01% 4943
2018
Q4
$50K Sell
251
-40
-14% -$12.2K ﹤0.01% 5477
2018
Q3
$181K Sell
291
-1,107
-79% -$491K ﹤0.01% 5090
2018
Q2
$479K Buy
+1,398
New +$504K ﹤0.01% 3989

Other funds holding TECX